Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration

NCT01134055 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

510

Enrollment

INDUSTRY

Sponsor class

Conditions

Macular Degeneration

Interventions

DRUG: pazopanib eye drops
DRUG: placebo
BIOLOGICAL: ranibizumab intravitreal injection

Sponsor

GlaxoSmithKline